NASDAQ:GRAY Graybug Vision (GRAY) Stock Price, News & Analysis $2.74 -0.17 (-5.84%) As of 08/8/2025 Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsSEC FilingsTrendsBuy This Stock About Graybug Vision Stock (NASDAQ:GRAY) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Graybug Vision alerts:Sign Up Key Stats Today's Range$2.66▼$2.9050-Day Range$1.43▼$3.8052-Week Range$5.00▼$22.12Volume25,238 shsAverage Volume2,165 shsMarket Capitalization$4.30 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Graybug Vision, Inc., a clinical-stage biopharmaceutical company, focuses on the development of medicines for the treatment of diseases of the retina and optic nerve. The company's lead product candidate is GB-102, an intravitreal injection of a microparticle depot formulation of sunitinib that is in Phase I/IIa and IIb clinical trials for the treatment of wet age-related macular degeneration, as well as in Phase IIa clinical trial to treat diabetic macular edema. It also develops GB-102, for the treatment of diabetic retinopathy; and GB-401, an intravitreally injected implant formulation of a beta-adrenergic receptor inhibitor to treat primary open-angle glaucoma. The company was formerly known as Graybug LLC and changed its name to Graybug Vision, Inc. in 2016. Graybug Vision, Inc. was incorporated in 2011 and is based in Redwood City, California. Read More Receive GRAY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Graybug Vision and its competitors with MarketBeat's FREE daily newsletter. Email Address GRAY Stock News HeadlinesGENAI ANNOUNCES CHANGE OF MANAGEMENT AND APPOINTMENT OF PATRICK GRAY AS CEOJanuary 6, 2025 | prnewswire.comOppenheimer Sticks to Its Buy Rating for CalciMedica (CALC)November 1, 2024 | markets.businessinsider.comThe Coin That Could Define Trump’s Crypto PresidencyWhen Trump returned to office, one of his first moves was to tap PayPal’s former COO, David Sacks, as a top advisor on crypto and AI. That alone signaled a shift. But insiders close to D.C. aren’t just talking crypto policy—they’re quietly buying something most retail investors have missed. While the crowd chases Bitcoin to $150,000, Weiss Ratings expert Juan Villaverde believes a different coin—already backed by giants like Google, Visa, and PayPal—could soon become crypto’s “Third Giant.”August 9 at 2:00 AM | Weiss Ratings (Ad)Age-Related Macular DegenerationOctober 23, 2024 | benzinga.comSeismic Therapeutic Appoints Julie Eastland as Independent Board DirectorSeptember 23, 2024 | finance.yahoo.comPhotobiomodulation for Early Dry AMD Gets Enthusiastic ReceptionJuly 25, 2024 | msn.comCould Metformin Fill the Bill for Geographic Atrophy Prevention?July 22, 2024 | msn.comGene Therapies for Neovascular AMD Continue to Show PromiseJuly 20, 2024 | msn.comSee More Headlines GRAY Stock Analysis - Frequently Asked Questions How have GRAY shares performed this year? Graybug Vision's stock was trading at $3.29 at the start of the year. Since then, GRAY shares have decreased by 16.7% and is now trading at $2.74. How were Graybug Vision's earnings last quarter? Graybug Vision, Inc. (NASDAQ:GRAY) announced its earnings results on Thursday, November, 11th. The company reported ($5.32) EPS for the quarter, missing analysts' consensus estimates of ($5.18) by $0.14. When did Graybug Vision's stock split? Graybug Vision's stock reverse split before market open on Monday, March 20th 2023.The 1-14 reverse split was announced on Monday, March 20th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Monday, March 20th 2023. An investor that had 100 shares of stock prior to the reverse split would have 7 shares after the split. When did Graybug Vision IPO? Graybug Vision (GRAY) raised $75 million in an IPO on Friday, September 25th 2020. The company issued 4,700,000 shares at a price of $15.00-$17.00 per share. SVB Leerink and Piper Sandler served as the underwriters for the IPO and Needham & Co. and Wedbush PacGrow were co-managers. How do I buy shares of Graybug Vision? Shares of GRAY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Graybug Vision own? Based on aggregate information from My MarketBeat watchlists, some other companies that Graybug Vision investors own include Tesla (TSLA), Plug Power (PLUG), Athenex (ATNX), NIO (NIO), Moderna (MRNA), Pinterest (PINS). Company Calendar Last Earnings11/11/2021Today8/09/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Pharmaceutical preparations Sub-IndustryN/A Current SymbolNASDAQ:GRAY CIK1534133 Webwww.graybug.com PhoneN/AFaxN/AEmployees27Year FoundedN/AProfitability EPS (Trailing Twelve Months)($24.23) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$35.60 million Net MarginsN/A Pretax MarginN/A Return on Equity-77.61% Return on Assets-71.34% Debt Debt-to-Equity RatioN/A Current Ratio10.73 Quick Ratio10.72 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$1.67 per share Price / Book1.64Miscellaneous Outstanding Shares1,571,000Free Float20,250,000Market Cap$4.30 million OptionableNot Optionable Beta1.20 Social Links The 10 Best AI Stocks to Own in 2025Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free Report This page (NASDAQ:GRAY) was last updated on 8/9/2025 by MarketBeat.com Staff From Our PartnersYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredHow high will gold surge?Weiss Gold Veteran Makes Shocking New Call Weiss expert Sean Brodrick went out on a limb last year and decl...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Graybug Vision, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Graybug Vision With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.